Dr. Christy Huff presented Safe Prescribing Protocols of Benzodiazepines: Lessons Learned from the Opioid Crisis alongside Dr. Alexis Ritvo on July 18, 2021.
[pdf id=17349]
Educating about the potential adverse effects of benzodiazepines taken as prescribed.
We received a new FDA communication dated August 3, 2022 about benzodiazepine use during pregnancy: This communication is to inform you that FDA is requiring manufacturers of all benzodiazepine medicines to update and standardize the…
Benzodiazepine Information Coalition recently responded to the FDA’s Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products. This document proposed by the FDA seeks to distinguish the difference between addiction,…
Please join us in welcoming Dr. Josef Witt-Doerring back our medical advisory board. Dr. Witt-Doerring is a board-certified psychiatrist who runs a private practice that specializes in helping patients safely discontinue psychiatric medications. Dr. Witt-Doerring interest…
In 2017 we started our MedWatch Reporting Program. This ongoing program gives patients information to report their own benzodiazepine experiences to the FDA. So far it has been a success. In September, 2020, the FDA…
Our director is presenting her lived benzodiazepine experience as a keynote speaker for the California Society of Addiction Medicine’s 2022 conference, August 24 through the 27th. The California Society of Addiction Medicine is the largest…
While the US and the world is convulsed by COVID-19, a dramatic admission has been made by the US Food and Drugs Administration about dangerous benzodiazepine drugs, acknowledging patients have suffered severe withdrawal side effects…